Comparative Study on Transcatheter Arterial Chemoembolization, Portal Vein Embolization and High Intensity Focused Ultrasound Sequential Therapy for Patients |
Cui, Lin
(Department of Chemotherapy, Affiliated Jiangsu Cancer Hospital of Nanjing Medical University & Jiangsu Institute of Cancer Research)
Liu, Xing-Xiang (Department of Oncology, Jiangyan People Hospital, the Affiliated Hospital of Yangzhou University) Jiang, Yong (Department of Chemotherapy, Affiliated Jiangsu Cancer Hospital of Nanjing Medical University & Jiangsu Institute of Cancer Research) Wu, Xing-Jun (Department of Oncology, Jiangyan People Hospital, the Affiliated Hospital of Yangzhou University) Liu, Jian-Jun (Department of Oncology, Jiangyan People Hospital, the Affiliated Hospital of Yangzhou University) Zhou, Xiang-Rong (Department of Chemotherapy, Affiliated Jiangsu Cancer Hospital of Nanjing Medical University & Jiangsu Institute of Cancer Research) He, Xue-Jun (Department of Chemotherapy, Affiliated Jiangsu Cancer Hospital of Nanjing Medical University & Jiangsu Institute of Cancer Research) Huang, Xin-En (Department of Chemotherapy, Affiliated Jiangsu Cancer Hospital of Nanjing Medical University & Jiangsu Institute of Cancer Research) |
1 | Yu ZJ, Meng XY, Chen JP, et al (1996). Clinical observations on the sequencial TACE, TSAI, and PVE treatment in advanced hepatocellular carcinoma with portal vein tumor thrombius. Chin J Dig, 16, 32-5. |
2 | Zhang L, Zhu H, Jin C, et al (2009). High-intensity focused ultrasound (HIFU): effective and safe therapy for hepatocellular carcinoma adjacent to major hepatic veins. Eur Radiol, 19, 437-45. DOI ScienceOn |
3 | Zhang LQ, Huang XE, Wang J (2011). The cyclin D1 G870A polymorphism and colorectal cancer susceptibility: a metaanalysis of 20 populations. Asian Pac J Cancer Prev, 12, 81-5. |
4 | Zhang XZ, Huang XE, Xu YL, et al (2012). Phase II study on voriconazole for treatment of Chinese patients with malignant hematological disorders and invasive aspergillosis. Asian Pac J Cancer Prev, 13, 2415-8. DOI |
5 | Zhou GX, Chen JP, Huang JF, et al (1998). Clinical observations on the sequencial TAE, PVE, and PEI treatment in advanced hepatocellular carcinoma. Chin J Oncol, 20, 312. |
6 | Zhou JN, Huang XE, Ye Z, et al (2009). Weekly paclitaxel/ Docetaxel combined with a paltinum in the treatment of advanced non-samll cell lung cancer: a study on efficacy, safety and pre-medication. Asian Pac J Cancer Prev, 10, 1147-50. |
7 | Zhou Q, Wang Y, Zhou X, et al (2011). Prognostic analysis for treatment modalities in hepatocellular carcinomas with portal vein tumor thrombi. Asian Pac J Cancer Prev, 12, 2847-50. |
8 | Li CG, Huang XE, Xu L, et al (2012). Clinical application of serum tumor associated material (TAM) from non-small cell lung cancer patients. Asian Pac J Cancer Prev, 13, 301-4. DOI |
9 | Li CG, Huang XE, Li Y, et al (2011). Phase II trial of irinotecan plus nedaplatin (INP) in treating patients with extensive stage small cell lung cancer. Asian Pac J Cancer Prev, 12, 487-90. |
10 | Gong P, Huang XE, Chen CY, et al (2012). Comparison on complications of peripherally inserted central catheters by ultrasound guide or conventional method in cancer patients. Asian Pac J Cancer Prev, 13, 1873-5. DOI |
11 | Huang XE, Li CG, Li Y, et al (2011). Weekly TP regimen as a postoperative adjuvant chemotherapy for completely resected breast cancer in China: final result of a phase II trial. Asian Pac J Cancer Prev, 12, 2797-800. |
12 | Jiang Y, Huang XE, Yan PW, et al (2010). Validation of treatment efficacy of a computer-assisted program for breast cancer patients receiving postoperative adjuvant chemotherapy. Asian Pac J Cancer Prev, 11, 1059-62. |
13 | Jin CB, Wu F, Wang ZB, et al (2003). High intensity focused ultrasound therapy combined with transcatheter arterial chemoembolization for advanced hepatocellular carcinoma. Chin J Oncol, 25, 401-3. |
14 | Kamsa-ard S, Wiangnon S, Suwanrungruang K, et al (2011). Trends in liver cancer incidence between 1985 and 2009, Khon Kaen, Thailand: cholangiocarcinoma. Asian Pac J Cancer Prev, 12, 2209-13. |
15 | Kim J, Chung DJ, Jung SE, et al (2012). Therapeutic effect of high-intensity focused ultrasound combined with transarterial chemoemb olisation for hepatocellular carcinoma smaller than 5 cm: comparison with transarterial chemoembolisation monotherapy--preliminary observations. Br J Radiol, 5, 293-9. |
16 |
Hua H, Qin S, Rui J, Li J (2011). Pharmacokinetics of arsenic trioxide |
17 | Yan PW, Huang XE, Yan F, et al (2011). Influence of MDR1 gene codon 3435 polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancer. Asian Pac J Cancer Prev, 12, 2291-4. |
18 |
Xu HX, Huang XE, Qian ZY, et al (2011). Clinical observation of |
19 | Xu T, Xu ZC, Zou Q, Yu B, Huang XE (2012). P53 Arg72Pro polymorphism and bladder cancer risk - meta- analysis evidence for a link in asians but not caucasians. Asian Pac J Cancer Prev, 13, 2349-54. DOI |
20 | Yan PW, Huang XE, Jiang Y, et al (2010). A clinical comparison on safety and efficacy of Paclitaxel/Epirubicin (NE) with Fluorouracil/Epirubicin/Cyclophosphamide (FEC) as postoperative adjuvant chemotherapy in breast cancer. Asian Pac J Cancer Prev, 11, 1115-8. |
21 | Yu DS, Huang XE, Zhou JN, et al (2012). A Comparative Study on the Value of Anal Preserving Surgery for Aged People with Low Rectal Carcinoma in Jiangsu, China. Asian Pac J Cancer Prev, 13, 2339-40. DOI |
22 | Lu JZ, Ji KX, Yu YQ, et al (1986). Observation of the blood supply of human hepatocellular carcinoma. Tumor, 6, 183-8. |
23 |
Li CG, Huang XE, Li Y, et al (2011). Clinical observations on safety and efficacy of |
24 | Li Y, Yan PW, Huang XE, et al (2011). MDR1 gene C3435T polymorphism is associated with clinical outcomes in gastric cancer patients treated with postoperative adjuvant chemotherapy. Asian Pac J Cancer Prev, 12, 2405-9. |
25 | Liu W, Li SY, Huang XE, et al (2012). Inhibition of tumor growth in vitro by a combination of extracts from Rosa roxburghii Tratt and Fagopyrum cymosum. Asian Pac J Cancer Prev, 13, 2409-14. DOI |
26 | Okusaka T, Odada S, Ueno H, et al (2000). Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma. Oncology, 58, 293-9. DOI ScienceOn |
27 |
O'Neill BE, Karmonik C, Li KC (2010). An optimum method for pulsed high intensity focused ultrasound treatment of large volumes using the InSightec |
28 | Parkin DM, Bray F, Ferlay J, et al (2005). Globle cancer statistics, 2002. CA Cancer J Clin, 55, 74-108. DOI ScienceOn |
29 | Pan WN, Mao SM, Li RX, et al (2001). Treatment of unresectable primary hepatic carcinoma with embolization and chemotherapy via hepatic artery and portal vein. J Hepatobiliary Sury, 9, 445-7. |
30 | Schwarz RE, Smith DD (2008). Trends in local therapy for hepatocellular carcinoma and survival outcomes in the US population. Am J Surg, 195, 829-36. DOI ScienceOn |
31 | Xu JW, Li CG, Huang XE, et al (2011). Ubenimex capsule improves general performance and chemotherapy related toxicity in advanced gastric cancer cases. Asian Pac J Cancer Prev, 12, 985-7. |
32 | Siperstein AE, Barber E (2001). Cryoablation percutaneous alcohol injection and radiofrequency ablation for treatment of neuroendocrine liver metastases. World J Sury, 25, 693-6. DOI ScienceOn |
33 | Society of Liver Cancer CACA (2000). The diagnosing standards for hepatocellular carcinoma. Chin J Hepatol, 8, 135. |
34 | Shu J, Li CG, Liu YC, et al (2012). Comparison of serum tumor associated material (TAM) with conventional biomarkers in cancer patients. Asian Pac J Cancer Prev, 13, 2399-403. DOI |
35 | Xu HX, Huang XE, Li Y, et al (2011). A clinical study on safety and efficacy of Aidi injection combined with chemotherapy. Asian Pac J Cancer Prev, 12, 2233-6. |
36 | Bridges JF, Joy SM, Gallego G, et al (2011). Needs for hepatocellular carcinoma control policy in the Asia-Pacific region. Asian Pac J Cancer Prev, 12, 2585-91. |
37 | Cheung TT, Chu FS, Jenkins CR, et al (2012).Tolerance of high-intensity focused ultrasound ablation in patients with hepatocellular carcinoma. World J Surg, 36, 2420-7. DOI ScienceOn |
38 | Cui L, Zhang ZS, Yu YQ, et al (2004). Treatment of primary hepatic carcinoma with double embolization and chemotherapy via hepatic artery and portal vein. Chin Clinical Oncol, 9, 404-5. |
39 | Gao LL, Huang XE, Zhang Q, et al (2011). A Cisplatin and vinorelbine (NP) regimen as a postoperative adjuvant chemotherapy for completely resected breast cancers in China: final results of a phase II clinical trial. Asian Pac J Cancer Prev, 12, 77-80. |
![]() |